The BSCA recommended baseline series is evidence-based, the other series are undergoing evaluation but represent the consensus view of the BSCA committee as the most likely allergens, outside the baseline series, to yield additional relevant positive reactions.
It is strongly recommended to test these series in addition to the baseline series and samples of the patients own products appropriately diluted.
Individual spreadsheets can be viewed by clicking on the tabs visible at the bottom of the sheets.
BSCA Series updated July 2023
Members, please login below to view this page
Your login is different to your BAD login. Non-members may apply for membership.
The updated BSCA 2023 medicament, steroid and facial series are now in the new document above (members only access).